Bromberg-Martin, E. S., Matsumoto, M. & Hikosaka, O. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 68, 815–834 (2010).
Gallo, E. F. & Posner, J. Moving towards causality in attention-deficit hyperactivity disorder: overview of neural and genetic mechanisms. Lancet Psychiatry 3, 555–567 (2016).
Barrot, M. et al. Braking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functions. J. Neurosci. 32, 14094–14101 (2012).
Morales, M. & Margolis, E. B. Ventral tegmental area: cellular heterogeneity, connectivity and behaviour. Nat. Rev. Neurosci. 18, 73–85 (2017).
Cohen, J. Y., Haesler, S., Vong, L., Lowell, B. B. & Uchida, N. Neuron-type-specific signals for reward and punishment in the ventral tegmental area. Nature 482, 85–88 (2012).
Brown, R. E. & McKenna, J. T. Turning a negative into a positive: ascending GABAergic control of cortical activation and arousal. Front. Neurol. 6, 135 (2015).
Dudman, J. T. & Krakauer, J. W. The basal ganglia: from motor commands to the control of vigor. Curr. Opin. Neurobiol. 37, 158–166 (2016).
Dalley, J. W. & Robbins, T. W. Fractionating impulsivity: neuropsychiatric implications. Nat. Rev. Neurosci. 18, 158–171 (2017).
Kala, K. et al. Gata2 is a tissue-specific post-mitotic selector gene for midbrain GABAergic neurons. Development 136, 253–262 (2009).
Lahti, L. et al. Differentiation and molecular heterogeneity of inhibitory and excitatory neurons associated with midbrain dopaminergic nuclei. Development 143, 516–529 (2016).
Bradley, C. K. et al. The essential haematopoietic transcription factor Scl is also critical for neuronal development. Eur. J. Neurosci. 23, 1677–1689 (2006).
Morello et al. Molecular fingerprint and developmental regulation of the tegmental gabaergic and glutamatergic neurons derived from the anterior hindbrain. Cell Reports 33, 108268 (2020).
Dillingham, C. M., Frizzati, A., Nelson, A. J. & Vann, S. D. How do mammillary body inputs contribute to anterior thalamic function? Neurosci. Biobehav. Rev. 54, 108–119 (2015).
Vann, S. D. Dismantling the Papez circuit for memory in rats. Elife 2, e00736 (2013).
Lammel, S. et al. Input-specific control of reward and aversion in the ventral tegmental area. Nature 491, 212–217 (2012).
Kimmel, R. A. et al. Two lineage boundaries coordinate vertebrate apical ectodermal ridge formation. Genes Dev. 14, 1377–1389 (2000).
Trokovic, R. et al. FGFR1 is independently required in both developing mid- and hindbrain for sustained response to isthmic signals. EMBO J. 22, 1811–1823 (2003).
Achim, K. et al. The role of Tal2 and Tal1 in the differentiation of midbrain GABAergic neuron precursors. Biol. Open 2, 990–997 (2013).
Cunningham, C. L., Gremel, C. M. & Groblewski, P. A. Drug-induced conditioned place preference and aversion in mice. Nat. Protoc. 1, 1662–1670 (2006).
Kiiskinen, T., Korpi, E. R. & Aitta-aho, T. Normal extinction and reinstatement of morphine-induced conditioned place preference in the GluA1-KO mouse line. Behav. Pharmacol. 30, 405–411 (2018).
Kopra, J. et al. Dampened amphetamine-stimulated behavior and altered dopamine transporter function in the absence of brain GDNF. J. Neurosci. 37, 1581–1590 (2017).
Valros, A. et al. Evidence for a link between tail biting and central monoamine metabolism in pigs (Sus scrofa domestica). Physiol. Behav. 143, 151–157 (2015).
Sagvolden, T., Aase, H., Zeiner, P. & Berger, D. Altered reinforcement mechanisms in attention-deficit/hyperactivity disorder. Behav. Brain Res. 94, 61–71 (1998).
Boonstra, A. M. et al. Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate. Sleep 30, 433–442 (2007).
Jansiewicz, E. M., Newschaffer, C. J., Denckla, M. B. & Mostofsky, S. H. Impaired habituation in children with attention deficit hyperactivity disorder. Cogn. Behav. Neurol. 17, 1–8 (2004).
Massa, J. & O’Desky, I. H. Impaired visual habituation in adults with ADHD. J. Atten. Disord. 16, 553–561 (2012).
Geyer, M. A. & Braff, D. L. Habituation of the Blink reflex in normals and schizophrenic patients. Psychophysiology 19, 1–6 (1982).
Kohl, S., Heekeren, K., Klosterkotter, J. & Kuhn, J. Prepulse inhibition in psychiatric disorders-apart from schizophrenia. J. Psychiatr. Res. 47, 445–452 (2013).
Braff, D. L., Geyer, M. A. & Swerdlow, N. R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156, 234–258 (2001).
Geyer, M. A. The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps? Neurotox. Res. 10, 211–220 (2006).
Leussis, M. P. & Bolivar, V. J. Habituation in rodents: a review of behavior, neurobiology, and genetics. Neurosci. Biobehav. Rev. 30, 1045–1064 (2006).
McDiarmid, T. A., Bernardos, A. C. & Rankin, C. H. Habituation is altered in neuropsychiatric disorders-A comprehensive review with recommendations for experimental design and analysis. Neurosci. Biobehav. Rev. 80, 286–305 (2017).
Groenman, A. P., Janssen, T. W. P. & Oosterlaan, J. Childhood psychiatric disorders as risk factor for subsequent substance abuse: a meta-analysis. J. Am. Acad. Child Adolesc. Psychiatry 56, 556–569 (2017).
Walcott, C. M. & Landau, S. The relation between disinhibition and emotion regulation in boys with attention deficit hyperactivity disorder. J. Clin. Child Adolesc. Psychol. 33, 772–782 (2004).
Lavezzi, H. N. & Zahm, D. S. The mesopontine rostromedial tegmental nucleus: an integrative modulator of the reward system. Basal Ganglia 1, 191–200 (2011).
Lammel, S., Lim, B. K. & Malenka, R. C. Reward and aversion in a heterogeneous midbrain dopamine system. Neuropharmacology 76, 351–359 (2014).
Lavezzi, H. N., Parsley, K. P. & Zahm, D. S. Modulation of locomotor activation by the rostromedial tegmental nucleus. Neuropsychopharmacology 40, 676–687 (2015).
Vento, P. J., Burnham, N. W., Rowley, C. S. & Jhou, T. C. Learning from one’s mistakes: a dual role for the rostromedial tegmental nucleus in the encoding and expression of punished reward seeking. Biol. Psychiatry 81, 1041–1049 (2017).
Bourdy, R. et al. Control of the nigrostriatal dopamine neuron activity and motor function by the tail of the ventral tegmental area. Neuropsychopharmacology 39, 2788–2798 (2014).
Brown, P. L. et al. Habenula-induced inhibition of midbrain dopamine neurons is diminished by lesions of the rostromedial tegmental nucleus. J. Neurosci. 37, 217–225 (2017).
Lorens, S. A., Kohler, C. & Guldberg, H. C. Lesions in Guddesn’s tegmental nuclei produce behavioral and 5-HT effects similar to those after raphe lesions. Pharm. Biochem. Behav. 3, 653–659 (1975).
Vann, S. D. Gudden’s ventral tegmental nucleus is vital for memory: re-evaluating diencephalic inputs for amnesia. Brain 132, 2372–2384 (2009).
Won, H. et al. GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice. Nat. Med. 17, 566–572 (2011).
Luo, S. X. et al. TGF-beta signaling in dopaminergic neurons regulates dendritic growth, excitatory-inhibitory synaptic balance, and reversal learning. Cell Rep. 17, 3233–3245 (2016).
Richter, M. M., Ehlis, A. C., Jacob, C. P. & Fallgatter, A. J. Cortical excitability in adult patients with attention-deficit/hyperactivity disorder (ADHD). Neurosci. Lett. 419, 137–141 (2007).
Moll, G. H., Heinrich, H., Trott, G., Wirth, S. & Rothenberger, A. Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate. Neurosci. Lett. 284, 121–125 (2000).
Hermann, B. et al. The frequency, complications and aetiology of ADHD in new onset paediatric epilepsy. Brain 130, 3135–3148 (2007).
Johnston, B. A. et al. Brainstem abnormalities in attention deficit hyperactivity disorder support high accuracy individual diagnostic classification. Hum. Brain Mapp. 35, 5179–5189 (2014).
Caye, A., Swanson, J. M., Coghill, D. & Rohde, L. A. Treatment strategies for ADHD: an evidence-based guide to select optimal treatment. Mol. Psychiatry 24, 390–408 (2018).
Bedingfield, J. B., Calder, L. D. & Karler, R. Comparative behavioral sensitization to stereotypy by direct and indirect dopamine agonists in CF-1 mice. Psychopharmacology 124, 219–225 (1996).
McNamara, R. K. et al. Dose-response analysis of locomotor activity and stereotypy in dopamine D3 receptor mutant mice following acute amphetamine. Synapse 60, 399–405 (2006).
Del Campo, N., Chamberlain, S. R., Sahakian, B. J. & Robbins, T. W. The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biol. Psychiatry 69, 145–157 (2011).
Robbins, T. W. & Arnsten, A. F. The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu. Rev. Neurosci. 32, 267–287 (2009).
Bymaster, F. P. et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27, 699–711 (2002).
Badgaiyan, R. D., Sinha, S., Sajjad, M. & Wack, D. S. Attenuated tonic and enhanced phasic release of dopamine in attention deficit hyperactivity disorder. PLoS ONE 10, e0137326 (2015).
Sagvolden, T., Russell, V. A., Aase, H., Johansen, E. B. & Farshbaf, M. Rodent models of attention-deficit/hyperactivity disorder. Biol. Psychiatry 57, 1239–1247 (2005).
Gainetdinov, R. R. Strengths and limitations of genetic models of ADHD. Atten. Defic. Hyperact. Disord. 2, 21–30 (2010).
Hess, E. J., Collins, K. A. & Wilson, M. C. Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation. J. Neurosci. 16, 3104–3111 (1996).
Myers, M. M., Musty, R. E. & Hendley, E. D. Attenuation of hyperactivity in the spontaneously hypertensive rat by amphetamine. Behav. Neural Biol. 34, 42–54 (1982).
van den Bergh, F. S. et al. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder. Pharm. Biochem. Behav. 83, 380–390 (2006).
Calzavara, M. B. et al. Effects of antipsychotics and amphetamine on social behaviors in spontaneously hypertensive rats. Behav. Brain Res. 225, 15–22 (2011).
Bizot, J. C. et al. Methylphenidate reduces impulsive behaviour in juvenile Wistar rats, but not in adult Wistar, SHR and WKY rats. Psychopharmacology 193, 215–223 (2007).
Del’Guidice, T. et al. Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice. Psychopharmacology 231, 109–122 (2014).
Moon, S. J. et al. Effect of atomoxetine on hyperactivity in an animal model of attention-deficit/hyperactivity disorder (ADHD). PLoS ONE 9, e108918 (2014).
Levin, R. et al. Spontaneously Hypertensive Rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 1748–1752 (2011).
Ralph, R. J., Paulus, M. P., Fumagalli, F., Caron, M. G. & Geyer, M. A. Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists. J. Neurosci. 21, 305–313 (2001).
Rodriguiz, R. M., Chu, R., Caron, M. G. & Wetsel, W. C. Aberrant responses in social interaction of dopamine transporter knockout mice. Behav. Brain Res. 148, 185–198 (2004).
Ramos, A. et al. Evaluation of Lewis and SHR rat strains as a genetic model for the study of anxiety and pain. Behav. Brain Res. 129, 113–123 (2002).
Goto, S. H., Conceicao, I. M., Ribeiro, R. A. & Frussa-Filho, R. Comparison of anxiety measured in the elevated plus-maze, open-field and social interaction tests between spontaneously hypertensive rats and Wistar EPM-1 rats. Braz. J. Med. Biol. Res. 26, 965–969 (1993).
Russell, V. A., Sagvolden, T. & Johansen, E. B. Animal models of attention-deficit hyperactivity disorder. Behav. Brain Funct. 1, 9 (2005).